Perrin Megan Wilson
CIK: 0002074091
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CLYM
Climb Bio, Inc.
Officer
Discretionary Trading P&L
Holdings
About Wilson Perrin Megan
Wilson Perrin Megan (SEC CIK 0002074091) files insider reports with the SEC as Chief Business Officer of Climb Bio, Inc. (CLYM).
Signal8 holds 2 ownership filings by Wilson Perrin Megan (1 Form 3, 1 Form 4), filed between Jun 23, 2025 and Jan 8, 2026. Those filings report 1 transaction, the latest on Jan 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Wilson Perrin Megan's filings is in WELLESLEY HILLS, MA.
Recent filings by Wilson Perrin Megan
- Jan 6, 2026: Grant or award of CLYM derivative securities (Form 4, code A).
Other insiders filing for Climb Bio, Inc. (CLYM)
- Thomas Stephen Basil, Director
- RA CAPITAL MANAGEMENT, L.P., Director
- Celebi Breanna Maurine, Director
- Levin Andrew David, Director
- Drapkin Kimberlee C, Director
- WILLIAMS DOUGLAS E, Director